Read the full stored bill text
SB 515 Text
skip navigation
SENATE
PRESIDENT
SENATORS
COMMITTEES
VIDEO/AUDIO
DISTRICT MAPS
SENATE CLERK
SENATE RULES
HOUSE
SPEAKER
DELEGATES
COMMITTEES
VIDEO/AUDIO
DISTRICT MAPS
HOUSE CLERK
HOUSE RULES
HOUSE STAFF
JOINT
INTERIM COMMITTEES
LEGISLATIVE ADMINISTRATOR
LEGISLATIVE SERVICES DIVISION
PUBLIC INFORMATION
LEGISLATIVE AUTOMATED SYSTEMS DIVISION
LEGISLATIVE AUDITOR'S OFFICE
PERFORMANCE EVALUATION & RESEARCH DIVISION
POST AUDIT DIVISION
BUDGET DIVISION
REGULATORY AND FISCAL AFFAIRS DIVISION
CLAIMS COMMISSION
CRIME VICTIMS
RULE-MAKING REVIEW
SPECIAL INVESTIGATIONS
JUDICIAL COMP. COMMISSION
JOINT RULES
STAFF INFO
BILL STATUS
BILL STATUS
BILL TRACKING
STATE LAW
WEST VIRGINIA CODE
ACTS OF THE LEGISLATURE
CODE OF 1931
WV CONSTITUTION
US CONSTITUTION
REPORTS
AGENCY REPORTS
AGENCY GRANT AWARDS
PERFORMANCE EVALUATIONS
POST AUDITS
EDUCATIONAL
CITIZEN’S GUIDE
INTERNSHIP PROGRAM
PAGE PROGRAM
PUBLICATIONS
PHOTO GALLERY
CAPITOL HISTORY
HOW A BILL BECOMES LAW
CONTACT
SENATE ROSTER
HOUSE ROSTER
PUBLIC INFO.
NEWS RELEASES
HELPFUL LINKS
Introduced Version
Senate Bill 515 History
|
Email
Key:
Green
= existing Code.
Red
= new code to be enacted
WEST VIRGINIA LEGISLATURE
2026
REGULAR SESSION
FISCAL NOTE
Introduced
Senate Bill 515
By Senator Takubo
[Introduced January 20, 2026; referred
to the Committee on Health and Human Resources; and then to the Committee on Finance]
A BILL to amend the Code of West Virginia, 1931, as amended, by adding a new section, designated §16B-13-4a, relating to drug testing for individuals in an office-based, medication-assisted treatment program; and providing a schedule of drug tests.
Be it enacted by the Legislature of West Virginia:
Article 13. medication-assisted treatment PROGRAM licensing act.
§16B-13-4a. Drug testing during progression of treatment for substance use disorder.
(a) Upon being admitted as a patient to an office-based medication-assisted treatment program, the provider shall perform a comprehensive, definitive drug test.
(b) After this time and continuing for six weeks, a direct observation, definitive test must be performed every two weeks for six weeks.
(c) Once the patient moves into the stabilization phase of treatment, the patient shall undergo a direct observation, presumptive test every 45 days for one year while in treatment.
(d) Following the stabilization phase of treatment, the patient moves into the maintenance phase of treatment and during the maintenance phase of treatment shall undergo a direct observation, presumptive test every six months thereafter until discharge from the program.
(e) At any point the provider wants to assess compliance, the patient must be willing to produce a direct observation presumptive or definitive test upon the provider request.
(f) Unexpected findings from presumptive test issued pursuant to this section may be subject to confirmation of results or testing of additional substances of concern for which presumptive testing is inadequate or unavailable by a definitive testing method.
NOTE: The purpose of this bill is to require drug tests for individuals receiving office-based medication-assisted treatment.
Strike-throughs indicate language that would be stricken from a heading or the present law and underscoring indicates new language that would be added.
Bill Status
|
Bill Tracking
|
Legacy WV Code
|
Bulletin Board
|
District Maps
|
Senate Roster
|
House Roster
|
Live
|
Blog
|
Jobs
|
Links
|
Home
This Web site is maintained by the
West Virginia Legislature's Office of Reference & Information.
|
Terms of Use
|
Webmaster
| © 2026 West Virginia Legislature **
Print On Demand
Name:
Email:
Phone: